Related Experiment Video

Updated: May 22, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Some notes on stem cell therapy in cardiovascular diseases

Mohammad Reza Mohammadhasani1, Mandana Hasanzad, Amirreza Mohammadhasani

  • 1Islamic Azad University, Tehran Medical Branch, Tehran, Iran.

ARYA Atherosclerosis
|May 12, 2012
PubMed

Insights

Cardiovascular diseases cause permanent heart damage. Stem cell therapy, including cardiac resident stem cells, offers a promising new approach to treat heart failure and improve patient outcomes.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Cardiovascular diseases (CVDs) are a growing global health concern, leading to irreversible cardiac tissue loss and heart failure.
  • Current treatments for CVDs offer moderate improvements in quality of life and prognosis, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

  • To explore the potential of cellular transplantation, specifically stem cell therapy, as a novel treatment for cardiovascular diseases.
  • To investigate the role of resident stem cells within the adult heart for potential therapeutic applications in cardiac repair.

Main Methods:

  • Review of existing clinical trials and pre-clinical studies involving various stem cell types for cardiovascular disease treatment.
  • Examination of research on resident stem cells in the adult heart and their potential contribution to cardiac regeneration.

Main Results:

  • Clinical trials using bone-marrow-derived cells and skeletal myoblasts have shown encouraging results in treating cardiac conditions.
  • Emerging evidence suggests the presence of resident stem cells in the adult heart, offering a potential autologous source for therapy.

Conclusions:

  • Cellular cardiomyoplasty and stem cell transplantation represent a significant advancement in addressing the limitations of current cardiovascular disease therapies.
  • Further clinical and pre-clinical research is essential to optimize stem cell therapy and harness the regenerative potential of cardiac resident stem cells for improved heart failure treatment.

Keywords:
Cardiovascular DiseaseIranStem Cell Therapy

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.